Xiangxue Pharmaceutical Co.,Ltd. (SHE:300147)

Market Cap	5.69B
Revenue (ttm)	1.71B
Net Income (ttm)	-910.63M
Shares Out	661.28M
EPS (ttm)	-1.40
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,786,988
Average Volume	30,322,213
Open	9.24
Previous Close	8.23
Day's Range	8.20 - 9.24
52-Week Range	3.16 - 16.49
Beta	0.49
RSI	60.05
Earnings Date	Aug 29, 2025

About Xiangxue Pharmaceutical

Xiangxue Pharmaceutical Co., Ltd. engages in the research and development, procurement, manufacture, delivery, and distribution of pharmaceutical products in China. It offers antivirotic oral liquids under the Xiangxue brand name; and healthcare supplements, as well as health solutions, such as food and beverage. Xiangxue Pharmaceutical Co., Ltd. has strategic partnership agreement with 111, Inc. to develop the Internet + Medicine model for China's traditional Chinese medicine industry. Xiangxue Pharmaceutical Co., Ltd. was founded in 1997 and ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1997
• Employees: 2,769
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300147

Financial Performance

In 2024, Xiangxue Pharmaceutical's revenue was 1.86 billion, a decrease of -19.16% compared to the previous year's 2.30 billion. Losses were -858.56 million, 120.7% more than in 2023.